Cargando…

Recent Advances in SARS-CoV-2 Main Protease Inhibitors: From Nirmatrelvir to Future Perspectives

The main protease (M(pro)) plays a pivotal role in the replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and is considered a highly conserved viral target. Disruption of the catalytic activity of M(pro) produces a detrimental effect on the course of the infection, making th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Citarella, Andrea, Dimasi, Alessandro, Moi, Davide, Passarella, Daniele, Scala, Angela, Piperno, Anna, Micale, Nicola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647625/ https://www.ncbi.nlm.nih.gov/pubmed/37759739 http://dx.doi.org/10.3390/biom13091339

Ejemplares similares

SARS-CoV-2 M(pro): A Potential Target for Peptidomimetics and Small-Molecule Inhibitors
por: Citarella, Andrea, et al.
Publicado: (2021)

Cyrene: A Green Solvent for the Synthesis of Bioactive Molecules and Functional Biomaterials
por: Citarella, Andrea, et al.
Publicado: (2022)

A Warhead Substitution Study on the Coronavirus Main Protease Inhibitor Nirmatrelvir
por: Vankadara, Subramanyam, et al.
Publicado: (2022)

Hydroxamic Acid-Based Histone Deacetylase (HDAC) Inhibitors Bearing a Pyrazole Scaffold and a Cinnamoyl Linker
por: Zagni, Chiara, et al.
Publicado: (2019)

Multicomponent Synthesis of the SARS-CoV-2 Main Protease Inhibitor Nirmatrelvir
por: Preschel, H. Daniel, et al.
Publicado: (2023)

Putative Inhibitors of SARS-CoV-2 Main Protease from A Library of Marine Natural Products: A Virtual Screening and Molecular Modeling Study
por: Gentile, Davide, et al.
Publicado: (2020)

Discovery of a Novel Trifluoromethyl Diazirine Inhibitor of SARS-CoV-2 M(pro)
por: Citarella, Andrea, et al.
Publicado: (2023)

Stabilization of the Dimeric State of SARS-CoV-2 Main Protease by GC376 and Nirmatrelvir
por: Paciaroni, Alessandro, et al.
Publicado: (2023)

Main protease mutants of SARS-CoV-2 variants remain susceptible to nirmatrelvir
por: Ullrich, Sven, et al.
Publicado: (2022)

Synthesis of potent and selective HDAC6 inhibitors led to unexpected opening of a quinazoline ring
por: Moi, Davide, et al.
Publicado: (2022)

Synthesis and Anti-HIV Profile of a Novel Tetrahydroindazolylbenzamide Derivative Obtained by Oxazolone Chemistry
por: Scala, Angela, et al.
Publicado: (2018)

State of the Art on Green Route Synthesis of Gold/Silver Bimetallic Nanoparticles
por: Scala, Angela, et al.
Publicado: (2022)

Naturally occurring mutations of SARS-CoV-2 main protease confer drug resistance to nirmatrelvir
por: Hu, Yanmei, et al.
Publicado: (2022)

Naturally Occurring Mutations of SARS-CoV-2 Main Protease Confer Drug Resistance to Nirmatrelvir
por: Hu, Yanmei, et al.
Publicado: (2023)

The history, mechanism, and perspectives of nirmatrelvir (PF-07321332): an orally bioavailable main protease inhibitor used in combination with ritonavir to reduce COVID-19-related hospitalizations
por: Joyce, Ryan P., et al.
Publicado: (2022)

Alkyne Derivatives of SARS-CoV-2 Main Protease Inhibitors Including Nirmatrelvir Inhibit by Reacting Covalently with the Nucleophilic Cysteine
por: Brewitz, Lennart, et al.
Publicado: (2023)

Structural basis of nirmatrelvir and ensitrelvir activity against naturally occurring polymorphisms of the SARS-CoV-2 main protease
por: Noske, Gabriela Dias, et al.
Publicado: (2023)

Peptidyl Fluoromethyl Ketones and Their Applications in Medicinal Chemistry
por: Citarella, Andrea, et al.
Publicado: (2020)

Pseudo-Dipeptide Bearing α,α-Difluoromethyl Ketone Moiety as Electrophilic Warhead with Activity against Coronaviruses
por: Citarella, Andrea, et al.
Publicado: (2021)

Autoprocessing and oxyanion loop reorganization upon GC373 and nirmatrelvir binding of monomeric SARS-CoV-2 main protease catalytic domain
por: Nashed, Nashaat T., et al.
Publicado: (2022)

Synthesis of C3/C1-Substituted Tetrahydroisoquinolines
por: Mihoubi, Mohamed, et al.
Publicado: (2015)

A study of proteases and protease-inhibitor complexes in biological fluids
por: Granelli-Piperno, A, et al.
Publicado: (1978)

Pharmacokinetics of Oral Nirmatrelvir/Ritonavir, a Protease Inhibitor for Treatment of COVID‐19, in Subjects With Renal Impairment
por: Toussi, Sima S., et al.
Publicado: (2022)

Substitutions in SARS-CoV-2 Mpro Selected by Protease Inhibitor Boceprevir Confer Resistance to Nirmatrelvir
por: Gammeltoft, Karen Anbro, et al.
Publicado: (2023)

Hotspot residues and resistance mutations in the nirmatrelvir-binding site of SARS-CoV-2 main protease: Design, identification, and correlation with globally circulating viral genomes
por: Padhi, Aditya K., et al.
Publicado: (2022)

H172Y mutation perturbs the S1 pocket and nirmatrelvir binding of SARS-CoV-2 main protease through a nonnative hydrogen bond
por: de Oliveira, Vinicius Martins, et al.
Publicado: (2022)

Recent Advances of Graphene-Based Strategies for Arsenic Remediation
por: Foti, Claudia, et al.
Publicado: (2020)

The Remarkable Selectivity of Nirmatrelvir
por: Duveau, Damien Y., et al.
Publicado: (2022)

Recent Advances and Challenges in Gene Delivery Mediated by Polyester-Based Nanoparticles
por: Piperno, Anna, et al.
Publicado: (2021)

Efficacy comparison of 3CL protease inhibitors ensitrelvir and nirmatrelvir against SARS-CoV-2 in vitro and in vivo
por: Kuroda, Takayuki, et al.
Publicado: (2023)

Supramolecular assembly of pentamidine and polymeric cyclodextrin bimetallic core–shell nanoarchitectures
por: Hada, Alexandru-Milentie, et al.
Publicado: (2022)

Nirmatrelvir-ritonavir for COVID-19
por: McDonald, Emily G, et al.
Publicado: (2022)

Nirmatrelvir and ritonavir for COVID-19
Publicado: (2022)

Global prevalence of SARS-CoV-2 3CL protease mutations associated with nirmatrelvir or ensitrelvir resistance
por: Ip, Jonathan Daniel, et al.
Publicado: (2023)

Hydroxamic Acid Derivatives: From Synthetic Strategies to Medicinal Chemistry Applications
por: Citarella, Andrea, et al.
Publicado: (2021)

SAR and QSAR of COVID-19 Main Protease–Inhibitor Interactions of Recently X-ray Crystalized Complexes
por: Ali, Hussein M., et al.
Publicado: (2022)

New Perspectives on Antimicrobial Agents: Molnupiravir and Nirmatrelvir/Ritonavir for Treatment of COVID-19
por: Atmar, Robert L., et al.
Publicado: (2022)

Molnupiravir and Nirmatrelvir/Ritonavir: Tolerability, Safety, and Adherence in a Retrospective Cohort Study
por: Mazzitelli, Maria, et al.
Publicado: (2023)

Discovery of 2-thiobenzimidazoles as noncovalent inhibitors of SARS-CoV-2 main protease
por: Deodato, Davide, et al.
Publicado: (2022)

Nirmatrelvir Plus Ritonavir: First Approval
por: Lamb, Yvette N.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e6ojnuaefrgke1n8vul56uj648